Esentra 120mg Injection

Esentra 120mg Injection is a chemical salt based anticancer medication. Therefore, Denosumab has several common side effects like any other medicine. Consult your doctor, if side effects persist for longer period of time.

• Musculoskeletal pain
  
• Pain in extremities
• Headache
  
• Constipation
  
• Rash
  
• Nerve pain
  
• Back pain
• Joint pain
  
• Abdominal discomfort
  
• Urinary tract infection
  
• Respiratory tract infection
  
• Hair loss
  
• Eczema
  
• Injection site reactions
  
• Osteonecrosis of the jaw
• Hypocalcemia

Esentra 120mg Injection is administered subcutaneously, depending on the cancer stage. Patients should not self-administer; it must be injected by a doctor or trained nurse. Consult a doctor for precise dosage and timing.

Esentra 120mg Injection contains 120mg of denosumab( a monoclonal antibody) works by binding to RANK ligand (RANKL), a protein essential for osteoclast formation, function, and survival. Esentra 120mg Injection reduces bone resorption, increases bone mineral density, and strengthens bone structure in osteoporosis or cancer-related to bone loss.

• Pageau, S. C. (2009, May). Denosumab. In MAbs (Vol. 1, No. 3, pp. 210-215). Taylor & Francis.
• Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., ... & Christiansen, C. (2009). Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England Journal of Medicine, 361(8), 756-765.
• Hanley, D. A., Adachi, J. D., Bell, A., & Brown, V. (2012). Denosumab: mechanism of action and clinical outcomes. International journal of clinical practice, 66(12), 1139-1146.
• Sheedy, K. C., Camara, M. I., & Camacho, P. M. (2015). Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis. Endocrine Practice, 21(3), 275-279.